Patricia T W Cohen

Title: The Innovations of Inventor Patricia T W Cohen

Introduction

Patricia T W Cohen, based in Dundee, GB, is an influential inventor recognized for his contributions to the field of biochemistry. With a keen focus on protein interactions, Cohen has developed significant innovations that have implications for medical research and treatment.

Latest Patents

Cohen holds a patent for a pivotal technology titled "Protein phosphatase 1 binding protein, R5 - Human PPP1R5 polypeptides and DNA (RNA) encoding such PPP1R5." This patent discloses not only the production of polypeptides via recombinant techniques but also methods for utilizing PPP1R5 in treating dysfunctions and diseases related to insulin resistance in glycogen synthesis. Furthermore, the patent describes agonists and antagonists of these proteins and methods for their application. Diagnostic assays to detect diseases associated with mutations in nucleic acid sequences and altered concentrations of these polypeptides are also included in this patent.

Career Highlights

Cohen has built a distinguished career at SmithKline Beecham Corporation, a leading pharmaceutical company. His work primarily revolves around enhancing our understanding of protein functions and their implications for various insulins resistant conditions, setting the groundwork for future therapeutic interventions.

Collaborations

Throughout his career, Patricia T W Cohen has collaborated with notable figures in the field, including Peter R Young and Phillip Cohen. These partnerships have enriched his research and contributed to a collaborative atmosphere aimed at solving complex biochemical challenges.

Conclusion

Patricia T W Cohen's contributions to the biomedical field through his patents and collaborations highlight the importance of innovation in addressing significant health issues. His work not only opens new avenues for research but also holds promise for improving therapeutic approaches in managing diseases related to insulin resistance.